Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Martin

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune responsePallavi Wadhone, Moitrayee Maiti, Reena Agarwal, et al.
Plos One|March 28, 2013
The human CD8β M-4 isoform dominant in effector memory T cells has distinct cytoplasmic motifs that confer unique propertiesDeepshi Thakral, Maria M Coman, Arunima Bandyopadhyay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapyManish Bodas, Nitya Jain, Amit Awasthi, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2010
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cellsTimothy J Haggerty, Ian S Dunn, Lenora B Rose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Identification and characterization of an alternative cancer-derived PD-L1 splice variantNadia B Hassounah, Venkat S Malladi, Yi Huang, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune responsePallavi Wadhone, Moitrayee Maiti, Reena Agarwal, et al.
Plos One|March 28, 2013
The human CD8β M-4 isoform dominant in effector memory T cells has distinct cytoplasmic motifs that confer unique propertiesDeepshi Thakral, Maria M Coman, Arunima Bandyopadhyay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapyManish Bodas, Nitya Jain, Amit Awasthi, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2010
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cellsTimothy J Haggerty, Ian S Dunn, Lenora B Rose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Identification and characterization of an alternative cancer-derived PD-L1 splice variantNadia B Hassounah, Venkat S Malladi, Yi Huang, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
Pageof 2